Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.

Abstract

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer’s disease (AD). Outpatients (Table 1), 50 years, with dementia of the Alzheimer’s type (DSM-IV-TR), MMSE 18 and receiving donepezil 6 months preceding screening, were eligible for… (More)
DOI: 10.1002/gps.1979

Topics

Cite this paper

@article{Waldemar2008TolerabilityOS, title={Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.}, author={Gunhild Waldemar and Maritta Hyv{\"a}rinen and Mette Krog Josiassen and Alex K\orner and Heikki Lehto and Peter Wetterberg}, journal={International journal of geriatric psychiatry}, year={2008}, volume={23 9}, pages={979-81} }